TREATMENT OF PANCREATIC CANCER WITH LIPOSOMAL IRINOTECAN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15403441

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A liposome-encapsulated formulation of irinotecan can be used for the treatment of pancreatic cancer in combination with 5-fluorouracil and leucovorin, including treatment of patients diagnosed with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERRIMACK PHARMACEUTICALS INCONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bayever, Eliel New York, US 26 196
Dhindsa, Navreet Boston, US 17 114
Fitzgerald, Jonathan Basil Arlington, US 43 295
Kim, Jaeyeon Lexington, US 70 441
Laivins, Peter Scituate, US 17 114
Moyo, Victor Ringoes, US 42 244
Niyikiza, Clet Gulph Mills, US 75 448

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation